Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
38.11
+0.15 (0.40%)
Aug 31, 2026, 4:00 PM EDT - Market closed

Astrana Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
40.5522.4943.1560.7245.1768.92
Depreciation & Amortization
63.0345.7527.9317.7517.5417.52
Other Amortization
4.594.051.831.060.941.08
Loss (Gain) From Sale of Investments
----1925.45
Loss (Gain) on Equity Investments
-----5.624.31
Stock-Based Compensation
40.7638.634.5422.0416.16.75
Other Operating Activities
-5.316.818.37-9.95-9.05-20.04
Change in Accounts Receivable
-9.42-9.42-35.77-20.57-38.19-1.52
Change in Accounts Payable
-6.99-6.99-30.92-0.17-0.053.22
Change in Income Taxes
5.335.33-8.62-14.486.92-14.01
Change in Other Net Operating Assets
-24.667.9911.6911.8329.37-21.33
Operating Cash Flow
107.87114.652.268.2382.1370.34
Operating Cash Flow Growth
-17.38%119.54%-23.49%-16.93%16.77%52.36%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-13.49-10.11-8.03-28.53-22.94-19.22
Cash Acquisitions
-552.34-548.6-146.26-6.51-16.353.34
Investment in Securities
15.115.1-5.97-0.3327.7132.37
Other Investing Activities
7.856.32-6.14-3.684.470.06
Investing Cash Flow
-544.6-539-192.4-65.52-7.1116.54

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1,119171.88284.533.6180.57
Long-Term Debt Repaid
--495.29-27.04-204.68-4.43-238.53
Total Debt Repaid
-167.87-495.29-27.04-204.68-4.43-238.53
Net Debt Issued (Repaid)
539.44624.01144.8379.85-0.83-57.97
Issuance of Common Stock
----8.639.06
Repurchase of Common Stock
-23.19-21.6-5.6-10.19-9.25-5.74
Common Dividends Paid
-1.85-7.89--62.07-14.03-31.09
Other Financing Activities
-12.28-25.18-4.09-4.16-4.6137.98
Financing Cash Flow
502.12569.35135.153.42-20.09-47.75

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
65.39144.94-5.056.1354.9339.13

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
94.38104.4944.1739.759.1951.11
Free Cash Flow Growth
-22.16%136.58%11.26%-32.93%15.80%13.58%
Free Cash Flow Margin
2.46%3.28%2.17%2.86%5.17%6.60%
Free Cash Flow Per Share
1.912.120.920.851.301.13
Levered Free Cash Flow
231.19227.9565.9274.5688.2733.57
Unlevered Free Cash Flow
271.81258.2384.7883.5792.2935.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
61.5845.7730.4214.256.674.16
Cash Income Tax Paid
--8.8543.9456.5747.3137.2
Change in Working Capital
-35.75-3.1-63.61-23.39-1.96-33.64
SEC Filings: 10-K · 10-Q